Atrial thrombus after the Fontan-operation: Predisposing factors, treatment and prophylaxis

Cardiology in the Young

Volumn 7, Issue 1, 1997, Pages 37-43

  Kaulitz, R ^a,b   Ziemer, G ^a   Bergmann, F ^a   Luhmer, I ^a   Kallfelz, H C ^a  

^a Medical School   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Fontan operation; Thrombolysis; Tissue plasminogen activator; Venous thrombosis

Indexed keywords

EID: 0002365224     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1047951100005849     Document Type: Article

References (24)

1. Choussat P, Fontan F, Besso P, Vallot F, Chauve A, Bricaud H. Selection criteria for Fontan's procedure. In: Anderson R, Shineborne E (eds): Paediatric Cardiology. Churchill-Livingstone, New York, 1977, pp 559-560.
2. Driscoll DJ, Offord KP, Felde RH, Schaff HV, Puga FJ, Danielson GK. Five-to fifteen-year follow-up after Fontan operation. Circulation 1992; 85: 469-496.
3. Mayer JE, Helgason H, Jonas RD, Lang P, Vargas FJ, Cook N, Castaneda AR. Extending the limits of modified Fontan precedures. J Thorac Cardiovasc Surg 1986; 92:1021-1028.
4. Mair DD, Hagler DJ, Pugs FJ, Schaff HV, Danielson GK. Fontan operation in 176 patients with tricuspid atresia. Circulation 1990; 82 (suppl. IV): IV-164-IV-169.
5. Bartmus D, Driscoll DJ, Offord KP, Humer RA, Mair DD, Schaff HV, Puga FJ, Danielson GK. The modified Fontan operation for children less than 4 years old. J Am Coll Cardiol. 1990; 15: 429-435.
6. Dobell ARC, Truster GA, Smallhorn JF, Williams WG. Atrial thrombi after the Fontan operation. Ann Throac Surg 1986; 42: 664-667.
7. Crome-Dijkhuis AH, Henkens CMA, Bijleveld CMA, Hillege HL, Bom VJJ, van der Meer J. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations. Lancet 1990; 336:1087-1090.
8. Mahony L, Nikaidoh H, Fixier DE. Thrombolytic treatment with streptokinase for late intraatrial thrombosis after modified Fontan procedure. Am J Cardiol 1988; 62: 343-344.
9. Shannon FL, Campbell DN, Clarke DR. Right atrial thrombosis: rare complication of the modified Fontan procedure. Pediatr Cardiol 1986; 7: 209-212.
10. Fontan F, Kirklin KW, Fernandez G, Costa F, Naftel D, Tritto F, Blackstone E. Outcome after a "perfect" Fontan operation. Circulation 1990; 81:1520-1536.
11. Jonas RA. Invited letter concerning: The importance of pulsatile flow when systemetic venous return is connected directly to the pulmonary arteries. J Thorac Cardiovasc Surg 1993; 105: 173-188.
12. De Leval MR, Kilner P, Gewillig M, Bull C. Total cavopulmonary connection: A logical alternative to atriopulmonary connection for complex Fontan operations. J Thorac Cardiovasc Surg 1988, 96: 682-695.
13. Jonas RA, Castaneda AR. Modified Fontan procedure: atrial baffle and systemic venous to pulmonary artery anastomotic techniques. J Cardiac Surg 1988; 3: 91-96.
14. Hedrick M. Elkins RC, Knott-Craig C, Razook JD. Successful thrombectomy for thrombosis of the right side of the heart after the Fontan operation. J Thorac Cardiovasc Surg 1993; 105: 297-301.
15. Kopf GS, Kleinman CS, Hijazi ZM, Fahey JT, Dewar ML, Hellenbrand WE. Fenestrated Fontan operation with delayed transcatheter closure of atrial septal defect. J Thorac Cardiovasc Surg 1992; 103: 1039-1048.
16. Stümper O, Sutherland GR, Geuskens R, Roelandt J, Bos E, Hess J. Transesophageal echocardiography in evaluation and management after a Fontan procedure. J Am Coll Cardiol 1991; 17:1152-1160.
17. Dajee H, Deutsch LS, Benson LN, Perloff JK, Laks H. Thrombolytic therapy for superior vena cava thrombosis following superior vena cava-pulmonary artery anastomosis. Ann Thorac Surg 1984; 38:637-639.
18. Okita Y, Miki S, Kusuhara K, Ueda Y, Tahata T, Komeda M, Tamura T. Massive systemic venous thrombosis after Fontan operation; report of a case. Thorac Cardiovasc Surg 1988; 36: 234-236.
19. Ino T, Benson LN, Freedom RM. Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. Am Heart J 1988; 115: 633-639.
20. Levy M, Benson LN, Burrows PE. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. Pediatr 1991; 118:467-472.
21. Marder VJ. The use of thrombolytic agents: choice of patients, drug administration, laboratory monitoring, Ann Intern Med 1979; 90:802.
22. Tuner-Gomes SO, Andrew M, Coles J, Trusler GA, Williams WG, Rabinovitch M. Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease. J Thorac Cardiovasc Surg 1992; 103: 87-97.
23. Cromme-Dijkhuis AH, Hess J, Hählen K, Henkens CMA, Bink-Boelkens M, Eygelaar AA, Bos E. Specific sequelae after Fontan operation at mid- and longterm folllow-up. J Thorac Cardiovasc Surg 1993; 106:1126-1132.
24. Hoek JA, ten Cate JW, Lamping J, Berends F, Borm JJ. Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes. Clin Chem 1988; 34:2058-2062.